Skip to content

Clinical trials

Recruiting Hematologic Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Status: Recruiting Country / region: Germany Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20172
20181
20201
20214
20222
20231
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC2
Munich Leukemia Laboratory2
Technical University of Munich2
CSL Behring1
Cogent Biosciences, Inc.1
Janssen Research & Development, LLC1
Kura Oncology, Inc.1
Miltenyi Biomedicine GmbH1
Prof. Dr. Thomas Luft1
Swedish Orphan Biovitrum1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms16
Leukemia4
Leukemia, Myeloid, Acute2
Lymphoma2
Lymphoma, Non-Hodgkin2
Multiple Myeloma2
Neoplasms2
Agammaglobulinemia1
Burkitt Lymphoma1
Fatigue1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.